Unibest
← Back to patent-cliff list

Lamivudine

Tier C — Watch / trade

Lamivudine

GSK
Originator
1995
First approval
-
Expiry (public)
$0.56B ▲
Peak sales
Small molecule
Type

Targets:RT

Brand:Zefix, Zeffix, Epivir

Indications (approved):Hepatitis B, Chronic hepatitis B, HIV infection

Regional status

US
Approved
1995-11-17
EU
Approved
1996-08-08
China
Approved
1999-03-08
Japan
Approved
1997-02-14

Factories producing this API1

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

1 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Sign in to view factories →

Synthetic routes & intermediates5 routes

Originator routes × 1Optimised (non-patent) × 4Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 6 · Total yield 165 mg
LAMI-0013376-59-8LAMI-00264904-47-8LAMI-00353608-94-9LAMI-004138760-43-7LAMI-00571-30-7LAMI-006143957-12-4LAMI-00798-91-9LAMI-0082032-35-1LAMI-009163348-46-7API · Lamivudine
CodeCAS No.Intermediate
LAMI-0013376-59-82,3-dihydroxypropyl benzoate
LAMI-00264904-47-82-oxoethyl benzoate
LAMI-00353608-94-92,2-diethoxyethanethiol
LAMI-004138760-43-7(5-ethoxy-1,3-oxathiolan-2-yl)methyl benzoate
LAMI-00571-30-7Available4-aminopyrimidin-2(1H)-one
LAMI-006143957-12-4((2R,5S)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl benzoate
LAMI-00798-91-9benzothioic O-acid
LAMI-0082032-35-12-bromo-1,1-diethoxyethane
LAMI-009163348-46-7S-(2,2-diethoxyethyl) benzothioate
OptimisedRoute 2Steps 4 · Total yield /
LAMI-00264904-47-8LAMI-006143957-12-4LAMI-01030163-03-2LAMI-011143957-11-3LAMI-012143957-14-6API · Lamivudine
CodeCAS No.Intermediate
LAMI-00264904-47-82-oxoethyl benzoate
LAMI-006143957-12-4((2R,5S)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl benzoate
LAMI-01030163-03-2(S)-2-hydroxy-3-mercaptopropanoic acid
LAMI-011143957-11-3(2R,5S)-2-((benzoyloxy)methyl)-1,3-oxathiolane-5-carboxylic acid
LAMI-012143957-14-6((2R)-5-acetoxy-1,3-oxathiolan-2-yl)methyl benzoate
OptimisedRoute 3Steps 5 · Total yield /
LAMI-00571-30-7LAMI-01389-78-1LAMI-0141152495-30-1LAMI-01526315-61-7LAMI-01640018-26-6LAMI-017—LAMI-018147126-65-6LAMI-019147027-10-9API · Lamivudine
CodeCAS No.Intermediate
LAMI-00571-30-7Available4-aminopyrimidin-2(1H)-one
LAMI-01389-78-1Available(1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol
LAMI-0141152495-30-12-oxoacetic acid hydrate
LAMI-01526315-61-7(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 2-oxoacetate
LAMI-01640018-26-61,4-dithiane-2,5-diol
LAMI-017-(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate
LAMI-018147126-65-6(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate
LAMI-019147027-10-9(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate
OptimisedRoute 4Steps 5 · Total yield /
LAMI-01389-78-1LAMI-018147126-65-6LAMI-02068-11-1LAMI-021298-12-4LAMI-022138760-34-6LAMI-023—LAMI-024200396-19-6LAMI-018-a147126-65-6API · Lamivudine
CodeCAS No.Intermediate
LAMI-01389-78-1Available(1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol
LAMI-018147126-65-6(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate
LAMI-02068-11-12-mercaptoacetic acid
LAMI-021298-12-4Available2-oxoacetic acid
LAMI-022138760-34-65-oxo-1,3-oxathiolane-2-carboxylic acid
LAMI-023-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-oxo-1,3-oxathiolane-2-carboxylate
LAMI-024200396-19-6(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate
LAMI-018-a147126-65-6(2S,5R)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate
OptimisedRoute 5Steps 3 · Total yield /
LAMI-00264904-47-8LAMI-012143957-14-6LAMI-01640018-26-6LAMI-02518027-23-1LAMI-0261091585-30-6API · Lamivudine
CodeCAS No.Intermediate
LAMI-00264904-47-82-oxoethyl benzoate
LAMI-012143957-14-6((2R)-5-acetoxy-1,3-oxathiolan-2-yl)methyl benzoate
LAMI-01640018-26-61,4-dithiane-2,5-diol
LAMI-02518027-23-1N-(trimethylsilyl)-N-(2-((trimethylsilyl)oxy)pyrimidin-4-yl)acetamide
LAMI-0261091585-30-6((2R,5S)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl benzoate

Frequently asked questions

What are the approved indications of Lamivudine?

Approved indications include: Hepatitis B, Chronic hepatitis B, HIV infection.

When does the Lamivudine patent expire?

No public expiry year is available for Lamivudine yet; this page updates once verified.

How many synthesis routes are recorded for Lamivudine?

5 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Lamivudine intermediates?

3 intermediate CAS of Lamivudine are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Lamivudine intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29